Granules India hosts analyst meet on September 18 in Hyderabad
- Granules India hosts analyst meet on September 18, 2026
- Session held in Hyderabad per SEBI LODR Regulation 30
- No unpublished price-sensitive info to be shared
- Schedule is tentative and subject to change

*this image is generated using AI for illustrative purposes only.
Granules India Limited will host a meeting with analysts, investors, and funds in Hyderabad on September 18, 2026. The session is part of the company's regular engagement with the investment community.
The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chaitanya Tummala, Company Secretary and Compliance Officer, confirmed the schedule on September 11, 2026.
Meeting Details
The management team will address queries from the investment community. The company stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting.
The schedule remains tentative and may be subject to changes due to difficulties faced by the company or the participants. Investors seeking updated financial information can access the latest investor presentation on the company’s website.
Regulatory Compliance
Granules India Limited is listed on both the National Stock Exchange of India Limited and BSE Limited. The disclosure ensures transparency and equal access to information for all stakeholders as mandated by securities regulations.
Historical Stock Returns for Granules
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.12% | +6.49% | +6.33% | +56.43% | +73.32% | 0.0% |
How might the management's responses to investor queries during this meeting influence Granules India's stock valuation in the near term?
What specific strategic initiatives or pipeline developments is the company likely to emphasize to attract institutional funds given the current pharma market climate?
Could this engagement signal an upcoming material corporate action, such as a rights issue or dividend revision, despite the disclaimer on unpublished price-sensitive information?


































